← Leaderboards
David O Beenhouwer
University Of California Los Angeles
$3,874,314
Attributed
$5,583,244
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $747.6K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,583,244 · 4
VA$0 · 1
By mechanism
R01$4,988,312 · 2
R21$362,192 · 1
K08$232,740 · 1
I01$0 · 1
Top collaborators
- Mario C. Deng5 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Mario C. Deng$4,076,811
- Judith S. Currier$525,401,794
- Sherie L Morrison$12,725,119
Others in their field
Top investigators on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$385,971,304
- Chanza Baytop · Westat, Inc.$271,217,917
- David R. Weir · University Of Michigan At Ann Arbor$186,776,551
- Barton F Haynes · Duke University$162,931,717
Research focus
ComplexDesignCellsResponseLinkSiteOrgan TransplantationMediatingYeastsImmune ResponseInfectionOrganismSymptomsPersonsChimeric ProteinsCryptococcus NeoformansBloodCessation Of LifeInflammatoryDoseEncapsulatedBiologicalToxic EffectPrevent
Grant awards (18)
Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients$682,291
R01 · FY2025 · AI
Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients$661,105
R01 · FY2024 · AI
Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients$661,105
R01 · FY2023 · AI
Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients$665,800
R01 · FY2022 · AI
Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients$747,559
R01 · FY2021 · AI
Enhancing the Delivery of Amphotericin B Across the Blood Brain Barrier for Treatment of Cryptococcal Meningoencephalitis$0
I01 · FY2021 · VA · contact PI
Enhancing the Delivery of Amphotericin B Across the Blood Brain Barrier for Treatment of Cryptococcal Meningoencephalitis$0
I01 · FY2020 · VA · contact PI
Enhancing the Delivery of Amphotericin B Across the Blood Brain Barrier for Treatment of Cryptococcal Meningoencephalitis$0
I01 · FY2019 · VA · contact PI
Enhancing the Delivery of Amphotericin B Across the Blood Brain Barrier for Treatment of Cryptococcal Meningoencephalitis$0
I01 · FY2018 · VA · contact PI
Antibody cytokine fusion proteins against Cryptococcus neoformans$310,937
R01 · FY2012 · AI · contact PI
Antibody cytokine fusion proteins against Cryptococcus neoformans$310,937
R01 · FY2011 · AI · contact PI
Antibody cytokine fusion proteins against Cryptococcus neoformans$314,078
R01 · FY2010 · AI · contact PI
Antidote for botulism$206,442
R21 · FY2010 · AI · contact PI
Antibody cytokine fusion proteins against Cryptococcus neoformans$317,250
R01 · FY2009 · AI · contact PI
Antidote for botulism$155,750
R21 · FY2009 · AI · contact PI
Antibody cytokine fusion proteins against Cryptococcus neoformans$317,250
R01 · FY2008 · AI · contact PI
SOMATIC MUTATION AND AUTOIMMUNITY$116,370
K08 · FY2001 · AI
SOMATIC MUTATION AND AUTOIMMUNITY$116,370
K08 · FY2000 · AI